Evidence map›Paper›PMID 21708111›Full record

ArticleHeart rhythm2011

Refining repolarization reserve.

Dan M Roden, Robert L Abraham

Abstract readEditorialComment
In one paragraph

Article in Heart rhythm, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A Brief Introduction to Management of LQTS.Reviews in cardiovascular medicine · 2022
    Article
  7. Progression of infarct-mediated arrhythmogenesis in a rodent model of heart failure.American journal of physiology. Heart and circulatory physiology · 2021
    Article
  8. Article
  9. Arrhythmogenic late CaProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  10. Article
  11. Article
  12. QT Assessment in Early Drug Development: The Long and the Short of It.International journal of molecular sciences · 2019
    Review
  13. BlindedFrontiers in pharmacology · 2019
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. The Electrogenic NaFrontiers in physiology · 2017
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Dan M Roden
Robert L Abraham

Funding

PHARMACOGENOMICS OF ARRHYTHMIA THERAPYU01HL065962 · NHLBI · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2001 to 2009
$24.8M
MODULATION OF CARDIAC REPOLARIZATIONR01HL049989 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 1994 to 2015
$5.2M
NHLBI NIH HHS R01 HL049989NHLBI NIH HHS U01 HL065962
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Computer SimulationAction PotentialsAnimalsAnti-Arrhythmia AgentsHeart VentriclesHumansLong QT SyndromeMyocytes, CardiacPotassium Channel BlockersAnti-Arrhythmia AgentsPotassium Channel Blockers

Identifiers

PMID21708111
PMCPMC3923504

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.